Title page
Article Outline
Optimizing Insulin Therapy for Type 2 Diabetes Mellitus
Guest Editor
Jeff Unger, MD
Director
Chino Medical Group Diabetes and
Headache Intervention Center
Chino California
This publication was supported by an unrestricted educational grant from Novo Nordisk Inc. Editorial support was provided by Watermeadow Medical USA Inc., New York, New York.
Statement of Peer Review: All supplement manuscripts submitted to The American Journal of Medicine for publication are reviewed by the Guest Editor(s) of the supplement, by an outside peer reviewer who is independent of the supplement project, and by the Journal's Supplement Editor (who ensures that questions raised in peer review have been addressed appropriately and that the supplement has an educational focus that is of interest to our readership).
Author Disclosure Policy: All authors contributing to supplements in The American Journal of Medicine are required to fully disclose any primary financial relationship with a company that has a direct fiscal or financial interest in the subject matter or products discussed in the submitted manuscripts, or with a company that produces a competing product. These relationships (e.g., ownership of stock or significant honoraria or consulting fees) and any direct support of research by a commercial company must be indicated on the title page of each manuscript. This information will be published in the frontmatter of each supplement.
Editor-in-Chief: Joseph S. Alpert, MD
Editor, Supplements: William H. Frishman, MD
Publishing Director: Pamela Poppalardo
Executive Supplements Editor: Brian Jenkins
Senior Production Editor: Mickey Kramer
Proof/Production Editor: Mary Crowell
PII: S0002-9343(08)00477-4
doi:10.1016/j.amjmed.2008.05.006

